Under pressure: cadaveric testing yields initial human organ validation for GT Capstone Expo winners’ minimally invasive treatment for cardiac arrest

Accelerator, Blog, Cardiology & Cardiothoracic, Design & Development, GCMI, How GCMI Supports Georgia Tech Innovators, Researchers, PIs and Students, News, Preclinical CRO Excellence

There are approximately 292,000 cases of in-hospital cardiac arrest every year for which the survival rate is less than 24 percent. Resuscitative efforts and supporting technologies are ineffective, slow, fatiguing, traumatic and expensive.   As their Fall 2020 Capstone Project, a group of students from the Georgia Tech Schools of Biomedical, Electrical and Mechanical Engineering…

How do you know you are ready for preclinical work? Insights and recording from our latest webinar.

Blog, GCMI, News, Physician Innovators, Preclinical CRO Excellence, T3, Webinar

How can medtech, life science and biopharma innovators know their product is ready for preclinical testing? GCMI Design and Development Director Mike Fisher and Preclinical Program Director Evan Goldberg joined Renovo Biomedical’s Anna Fallon on January 14, 2021 to answer that question.

Testing beyond the bench: how GCMI supported GT Capstone’s “Incisionizers” with early stage validation testing for its novel retraction device.

Blog, Design & Development, GCMI, How GCMI Supports Georgia Tech Innovators, Researchers, PIs and Students, News, Preclinical CRO Excellence

Georgia Tech recently completed its Fall 2020 (virtual) Capstone Design Expo. From the project’s website, “The Capstone Design Expo showcases Georgia Tech’s graduating seniors as they present their innovative projects designed and built during the Capstone Design Course. Students work in teams to solve either an industry problem, develop innovative tools to assist researchers, or…

News: Georgia Tech Names Raghupathy Sivakumar Inaugural Interim Chief Commercialization Officer

Accelerator, Blog, Design & Development, GCMI, News

Last month, Georgia Tech named Raghupathy “Siva” Sivakumar inaugural Interim Chief Commercialization Officer. From Georgia Tech Research Horizons:   “Sivakumar will bring together commercialization and technology transfer activities from across campus with a goal of moving more intellectual property out into the marketplace to help expand Georgia Tech’s impact on the world. Attaining that goal…

How do you know you are ready for preclinical work? Join us for a free webinar on January 14.

Accelerator, Blog, Cardiology & Cardiothoracic, Design & Development, Event, Events, GCMI, GI, neurology, orthopedic, Physician Innovators, Preclinical CRO Excellence, Regenerative Medicine, spine, T3, Webinar

Preclinical evaluations are often the best way to assess a medical product’s performance, and regulatory bodies often require preclinical data in product submissions.  But this type of work is also expensive. The most effective product development strategies use preclinical studies wisely. The most expensive preclinical study is the one you have to repeat.   How…

Medtech Innovators and Investors: Are You Wasting Cash In Design & Development?

Accelerator, Agency, Blog, Cardiology & Cardiothoracic, Design & Development, GCMI, News, orthopedic, Physician Innovators, Preclinical CRO Excellence, spine, Uncategorized

Watch, listen and learn. Our 2020 AdvanSE session can help you know, and fix, the ways medtech innovators burn cash unnecessarily.    Too many promising medtech innovations and early stage companies fail unnecessarily because they run out of funding before achieving milestones required for next-round investments.    It is possible to know earlier in the…

Learn more about: PreClinical CRO, Med Device Design, Development, Prototyping and More with GCMI.

Accelerator, Agency, Blog, Design & Development, GCMI, Physician Innovators

Medtech and life science innovation is a complex, costly endeavor. How do you know you are on the right regulatory track? What activities need to happen in which order to achieve key milestones efficiently?   Preclinical work is expensive and the most expensive study is the one you have to do twice.   GCMI helps…

ALung Technologies granted Emergency Use Authorization by the FDA for their Hemolung® Respiratory Assist System for the Treatment of COVID-19

Accelerator, Blog, Cardiology & Cardiothoracic, GCMI, News, Preclinical CRO Excellence, T3, Uncategorized

A long-time customer of GCMI and T3 Labs, ALung Technologies, has recently announced that they have received FDA Emergency Use Authorization (EUA) for their Hemolung® Respiratory Assist System (RAS), the world’s first fully-integrated respiratory dialysis system. This system removes carbon dioxide directly from the blood, allowing the patient’s lungs to rest and heal while avoiding…